Skip to content

New Relapse Model in Psychiatry

Creation of a Visualization Tool With Integrated Clinical Data to Support Clinical Intervention and Empowerment of Inpatients in Psychiatry : Basis for the Development of a Predictive Model of Relapse

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06244641
Acronym
NRMP
Enrollment
350
Registered
2024-02-06
Start date
2024-11-12
Completion date
2028-02-01
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Keywords

clustering, relapse, feedback-measurment-system

Brief summary

The goal of this clinical trial is to learn about risk factors of relapse in patients with alcohol use disorder. The main questions it aims to answer are : * Among patients with Alcohol Use Disorder, are there clusters of patients with the same characteristics and the same outcome ? * Which are the risk factors of relapse that are the most predictive ? Do they vary according to cluster? * Can a feedback-measurment-system (eg : a feedback of the tests' results) be usefull in a detoxification unit ? Participants will : * Complete auto-questionnaires * Pass hetero-evaluations * Undergo an electrophysiological battery

Interventions

OTHERAuto-questionnaires, hetero-questionnaires and Evoked-potentials

Evaluations of risk factors of relapse by questionnaires, evaluation of evoked-potentials

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER
Fonds National de la Recherche Scientifique
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To suffer from AUD * To be hospitalized * To speak French fluently * To be able to give their consent (medically and legally).

Exclusion criteria

* To suffer from severe perceptive disabilities (auditory, visual) * To suffer from severe cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Relapse or abstinence after detoxificationThroughout the entire study, approximately during 48 monthsnumber of alcohol units and time to relapse or abstinence after detoxification

Secondary

MeasureTime frameDescription
Satisfaction of the feedback-measurment-system for clinicians and patientsThroughout the entire study, approximately during 48 monthsSimple questions with Likert-scale to evaluate the feedback-measurment-system

Countries

Belgium

Contacts

CONTACTClaire Emmanuèle Marie Ledouble
claireledouble@hotmail.com+32474731113
CONTACTPhilippe de Timary, PhD
philippe.detimary@uclouvain.be+3227642160
PRINCIPAL_INVESTIGATORPhilippe de Timary, PhD

Université catholique de Louvain (Wallonia)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026